Biotechnology - Lexington, Massachusetts, United States
VREX Therapeutics Inc. is a recently announced Cambridge, MA based company founded on the next generation of HSV1 based oncolytic immuno-gene therapy platform. We have generated a compelling set of preclinical data demonstrating in-vitro and in-vivo POC against 11 different cancer types, 20 different cancer cell lines with clearly demonstrated abscopal effect in mice. We believe our platform has significant advantages to other HSV1 based platforms in early and late clinical development
Outlook
GoDaddy Hosting
Mobile Friendly